MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 126 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $823 | -84.3% | 5,636 | -75.1% | 0.00% | -75.0% |
Q2 2023 | $5,230 | +74.6% | 22,642 | +83.1% | 0.00% | +33.3% |
Q1 2023 | $2,995 | -99.0% | 12,364 | +154.9% | 0.00% | – |
Q3 2022 | $315,000 | -18.6% | 4,850 | -10.3% | 0.00% | – |
Q2 2022 | $387,000 | -62.1% | 5,407 | -48.1% | 0.00% | -100.0% |
Q1 2022 | $1,022,000 | +149.3% | 10,421 | +114.9% | 0.00% | – |
Q4 2021 | $410,000 | -74.5% | 4,850 | -70.1% | 0.00% | -100.0% |
Q3 2021 | $1,611,000 | +2.4% | 16,214 | +0.3% | 0.00% | 0.0% |
Q2 2021 | $1,574,000 | +177.6% | 16,163 | +233.3% | 0.00% | +100.0% |
Q1 2021 | $567,000 | +5.2% | 4,850 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $539,000 | -52.6% | 4,850 | -49.4% | 0.00% | -50.0% |
Q3 2020 | $1,138,000 | -66.4% | 9,589 | -68.0% | 0.00% | -60.0% |
Q2 2020 | $3,390,000 | +100.8% | 29,936 | +18.3% | 0.01% | +66.7% |
Q1 2020 | $1,688,000 | +127.8% | 25,299 | +210.8% | 0.00% | +50.0% |
Q4 2019 | $741,000 | +21.9% | 8,141 | +15.4% | 0.00% | 0.0% |
Q3 2019 | $608,000 | -8.7% | 7,057 | +11.0% | 0.00% | 0.0% |
Q2 2019 | $666,000 | +39.9% | 6,359 | +67.3% | 0.00% | +100.0% |
Q1 2019 | $476,000 | +11.0% | 3,802 | -0.1% | 0.00% | 0.0% |
Q4 2018 | $429,000 | +84.9% | 3,807 | +250.9% | 0.00% | 0.0% |
Q3 2018 | $232,000 | – | 1,085 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |